

Fundamental dimension Equity attribute | MCOLeader $481.77▼-1.89% Cap $83.07BP/E 29.3x QuantScore62/100 | EXPGYPeer $41.35▼-0.05% Cap $36.58BP/E 25.2x QuantScore60/100 | FDSPeer $331.32▼-1.23% Cap $11.78BP/E 22.7x QuantScore52/100 |
|---|---|---|---|
1. QuantScore pillars0–100 per pillar · click a ticker for the factor breakdown | |||
Technical | |||
95/100 |
73/100 |
73/100 |
Valuation Multiples, PEG & DCF upside | 56/100 | 75/100 | 81/100 |
Health Piotroski, Altman Z, leverage & liquidity | 64/100 | 55/100 | 49/100 |
Growth Revenue / earnings growth & margins | 48/100 | 34/100 | 25/100 |
Sentiment Analyst ratings, targets & revisions | 45/100 | 61/100 | 33/100 |
2. Valuation multiples & capital pricingGreen highlight = best-in-class (lowest positive multiple) |
Trailing P/E | 29.3x | 25.2x | 22.7x |
Forward P/E (next FY) | 28.7x | 20.5x | 16.8x |
EV / EBITDA (TTM) | 23.1x | 13.5x | 14.3x |
Price / Sales | 10.2x | 4.3x | 4.8x |
Price / Free Cash Flow | 26.3x | 16.9x | 16.7x |
PEG ratio | 0.92 | 0.84 | -3.16 |
3. Financial health & solvencyLatest filings |
Piotroski F-Score | 8 / 9 | 7 / 9 | 7 / 9 |
Altman Z-Score | 7.69 (Safe) | 5.62 (Safe) | 4.33 (Safe) |
Total debt / equity | 2.29 | 1.00 | 0.77 |
Quick ratio | 1.3x | 0.9x | 0.6x |
Interest coverage | 18.1x | 9.9x | 8.6x |
4. Growth & margins trajectoryLatest fiscal year |
Revenue growth YoY | +8.9% | +12.6% | +6.7% |
Net income growth YoY | +19.5% | +29.2% | -10.6% |
Gross margin (TTM) | 73.1% | 25.3% | 50.6% |
Operating margin (FY) | 44.8% | 25.4% | 28.3% |
FCF margin (FY) | 33.4% | 25.9% | 28.6% |
5. Trailing price performancePrice change over period |
1M return | +3.4% | +16.6% | +22.1% |
3M return | +2.5% | +17.0% | +30.3% |
6M return | +6.0% | +11.0% | +47.8% |
Year to date | -5.4% | -8.5% | +14.2% |
1Y return | -1.5% | -14.7% | +16.1% |
3Y return | +58.2% | +26.4% | -22.9% |
6. DCF valuation & street consensusDCF model · analyst consensus |
DCF model fair value | $170.92 -64.5% premium | $34.66 -16.2% premium | $373.28 +12.7% upside |
Wall Street consensus target | $536.44 +11.3% · range $480.00–$595.00 | — — | $256.75 -22.5% · range $215.00–$301.00 |
Consensus stance | 56% Buy41% Hold3% Sell | 67% Buy33% Hold0% Sell | 10% Buy67% Hold23% Sell |